GNPAT

Chr 1AR

glyceronephosphate O-acyltransferase

Also known as: DAP-AT, DAPAT, DHAPAT, RCDP2

The protein functions as dihydroxyacetonephosphate acyltransferase, catalyzing the first step in plasmalogen biosynthesis within peroxisomal membranes. Mutations cause rhizomelic chondrodysplasia punctata type 2, a severe disorder affecting skeletal development, growth, and neurological function. Inheritance is autosomal recessive.

OMIMResearchSummary from RefSeq, OMIM, UniProt
LOFmechanismARLOEUF 0.421 OMIM phenotype
Clinical SummaryGNPAT
🧬
Gene-Disease Validity (ClinGen)
glyceronephosphate O-acyltransferase deficiency · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.23) despite low pLI — interpret in context.

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint
0.42LOEUF
pLI 0.304
Z-score 4.19
OE 0.23 (0.140.42)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint
0.67Z-score
OE missense 0.90 (0.820.99)
316 obs / 351.5 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.23 (0.140.42)
00.351.4
Missense OE0.90 (0.820.99)
00.61.4
Synonymous OE1.01
01.21.6
LoF obs/exp: 8 / 34.6Missense obs/exp: 316 / 351.5Syn Z: -0.06

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

GNPAT · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →